ARCHIVES

AACI’s “12 Tasks” Outlined to Board

This article is from The Cancer Letter archive.

Vol. 01 No. 13 | March 28, 1975

Download PDF Visit The Full Archive

Related Articles

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It

February 6, 1976

Stories On Proscar Cause Confusion In Prostate Cancer Prevention Trial

September 6, 1996

New Cancer Education Grant Program Guidelines, Developed

February 6, 1987

In Brief: Coalition Begins Campaign To Educate Public

February 3, 1995

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007